Omnicell (OMCL) Liabilities and Shareholders Equity (2010 - 2026)

Omnicell (OMCL) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $2.0 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 6.85% year-over-year to $2.0 billion; the TTM figure through Mar 2026 stood at $8.1 billion (down 8.96% YoY), while the FY2025 annual figure was $2.0 billion, down 6.89% from the prior year.
• Liabilities and Shareholders Equity improved to $2.0 billion in Q1 2026 per OMCL's latest filing, from $2.0 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.3 billion in Q3 2024 and bottomed at $1.9 billion in Q3 2025.
• Historically, Liabilities and Shareholders Equity has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2022.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity advanced 12.51% — and 2025, when it decreased 15.41%.
• Omnicell's Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then grew by 0.73% to $2.2 billion in 2023, then fell by 4.76% to $2.1 billion in 2024, then dropped by 6.89% to $2.0 billion in 2025, then grew by 1.49% to $2.0 billion in 2026.
• Business Quant data shows OMCL's Liabilities and Shareholders Equity at $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.9 billion in Q3 2025.